
Wall Street Journal - October 14, 2003
Marilyn Chase, Staff Reporter of The Wall Street Journal
Last year Mr. Gates, the Microsoft founder-turned-philanthropist, visited India and pledged $100 million to fight AIDS in the subcontinent, where the next wave of the disease is expected to explode.
Currently, India has 4.5 million people infected with human immune-deficiency virus, the virus that causes AIDS. By 2010, India's caseload is expected to soar to between 20 million and 25 million people -- the highest estimate for any country -- according to a 2002 National Intelligence Council report to the Central Intelligence Agency.
The new grants, announced in New Delhi Monday, aim to decrease prevalence of HIV in high-risk groups, and stabilize it in the country's general population by 2008, said Prasada Rao, co-chairman of the board of the India AIDS Initiative.
With infection rates rising as much as 20% a year, India is at a "critical juncture," said Helene Gayle, director of the Gates Foundation's HIV/AIDS, TB and Reproductive Health Program. "We have only a small window of opportunity to prevent a widespread epidemic."
The money will help fund two broad prevention initiatives. The first offers comprehensive prevention services to high-risk populations in six hard-hit Indian states, including male and female sex workers, their clients, intravenous-drug users and others. Services include treatment of sexually transmitted diseases, voluntary testing and counseling, behavior change and condom promotion.
The second prevention project will address truckers and sex workers along 4,340 miles of roadways in India with clinics for sexually transmitted diseases, testing, condoms and behavior-change programs.
The expanded commitment and grant awards are an outgrowth of the trip Mr. Gates made to India last year. Led by his father, William H. Gates Sr., the foundation has about $25 billion in assets aimed at improving global health and education.
Write to Marilyn Chase at marilyn.chase@wsj.com
031014
WJ031004
Copyright © 2003 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .